Current Search Criteria:
Intervention: Live, attenuated dengue serotype 1, 2, 3, and 4 virus
Found 18 matching trials
Safety of and Immune Response to a Dengue Virus Vaccine (rDEN3/4delta30[ME]) in Healthy Adults
PHASE1Dengue fever, caused by dengue viruses, is a major health problem in the tr...
Location
Center for Immunization Research
Safety of and Immune Response of a 2-dose Regimen of rDEN1delta30 Dengue Virus Vaccine
PHASE1Dengue fever, caused by dengue viruses, is a major health problem in tropic...
Location
Center for Immunization Research, Johns Hopkins School of Public Health
Study of a Tetravalent Dengue Vaccine in Healthy Children Aged 2 to 11 Years in Malaysia
PHASE3The purpose of this study was to evaluate the safety and immunogenicity of ...
Location
Multiple Locations
Study of a Tetravalent Dengue Vaccine in Healthy Adult Subjects Aged 18 to 45 Years in India
PHASE2The aim of this study is to evaluate the immunogenicity and safety of the C...
Location
Multiple Locations
Trial to Model Primary, Secondary, and Tertiary Dengue Using a Monovalent Vaccine
PHASE1Background:
Dengue is a disease caused by a virus transmitted by mosquitoe...
Location
National Institutes of Health Clinical Center
Study of a Novel Tetravalent Dengue Vaccine in Healthy Children and Adolescents Aged 9 to 16 Years in Latin America
PHASE3The aim of the study was to assess the efficacy of Sanofi Pasteur's CYD den...
Location
Multiple Locations
Study of CYD Dengue Vaccine in Healthy Children and Adolescents in South America
PHASE2The purpose of this study is to generate immunogenicity and safety data in ...
Location
Multiple Locations
A Phase 1 Safety Study of Dengusiil in Healthy Adults
PHASE1This is a Phase 1 study to assess safety and tolerability of a single subcu...
Location
CMAX Clinical Research Pty Ltd
Safety and Immunogenicity With Two Different Serotype 2 Potencies of Takeda's Tetravalent Dengue Vaccine Candidate (TDV) in Adults in Singapore
PHASE2The purpose of this study is to assess the post-vaccination neutralizing an...
Location
Singapore General Hospital
Immune Response to Different Schedules of a Tetravalent Dengue Vaccine Given With or Without Yellow Fever Vaccine
PHASE2The aim of this study was to evaluate the administration of CYD dengue vacc...
Location
Multiple Locations
Treatments Being Tested
Live, attenuated, recombinant dengue serotypes 1, 2, 3, and 4 virusLive, attenuated, recombinant dengue serotypes 1, 2, 3, and 4 virusLive, attenuated, recombinant dengue serotypes 1, 2, 3, and 4 virusYellow Fever